Small Cap Biotech
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).
Trend Stats
1-Month Return
+13.37%
3-Month Return
+6.41%
12-Month Return
+76.32%
Volatility Score
2.7
RSI
62.9
ST Trend
Up
LT Trend
Up
Short-Term Trend
Up
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Small Cap Biotech
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie | $363B | +21.88% | -4.32% | +0.85% | 2.5 | Down | Down |
| AMGN | Amgen | $186B | +27.76% | +1.06% | -0.85% | 2.2 | Down | Up |
| GILD | Gilead Sciences | $165B | +29.69% | +3.82% | -2.86% | 2.4 | Down | Up |
| VRTX | Vertex Pharma | $111B | -10.99% | -5.32% | -3.83% | 2.5 | Down | Down |
| REGN | Regeneron Pharma | $79B | +28.34% | -0.14% | +1.98% | 2.4 | Down | Up |
| ALNY | Alnylam Pharma | $41B | +30.28% | -15.60% | -1.20% | 4.1 | Down | Down |
| RVMD | REVOLUTION MEDIC | $31B | +303.96% | +26.69% | +55.46% | 4.3 | Up | Up |
| INSM | Insmed | $30B | +97.89% | -9.81% | +3.66% | 4.6 | Down | Down |
| NTRA | Natera | $29B | +42.04% | -15.39% | +5.19% | 4.9 | Neutral | Up |
| BIIB | Biogen | $27B | +56.41% | +7.72% | +2.47% | 3.2 | Neutral | Up |
| UTHR | United Therapeut | $25B | +95.84% | +22.07% | +9.38% | 3.3 | Up | Up |
| MRNA | MODERNA | $22B | +110.68% | +8.87% | +5.55% | 5.1 | Up | Up |
| ROIV | ROIVANT SCIENCES | $21B | +181.09% | +27.46% | +5.74% | 3.2 | Up | Up |
| SMMT | SUMMIT THERAP | $20B | -3.55% | +56.56% | +70.08% | 5.5 | Up | Up |
| INCY | Incyte | $19B | +67.69% | -8.07% | +5.99% | 2.7 | Down | Up |
| BBIO | BRIDGEBIO PHARMA | $15B | +122.88% | -2.52% | +11.15% | 3.6 | Up | Up |
| NBIX | Neurocrine Biosc | $13B | +27.99% | -3.83% | +1.99% | 3.2 | Down | Down |
| IONS | Ionis Pharmaceut | $12B | +157.60% | -5.87% | +5.34% | 3.2 | Down | Up |
| MDGL | Madrigal Pharmct | $12B | +74.32% | +6.18% | +19.61% | 4.6 | Up | Up |
| EXEL | Exelixis | $12B | +25.79% | +2.41% | +11.19% | 2.7 | Up | Up |
| BMRN | Biomarin Pharm | $11B | -11.19% | -3.79% | +0.91% | 2.6 | Down | Down |
| ARWR | Arrowhead Phrmct | $9.9B | +474.84% | +5.10% | +26.13% | 4.8 | Up | Up |
| PRAX | PRAXIS PRECIS | $9.5B | +847.30% | +9.03% | +14.26% | 5.7 | Up | Up |
| PCVX | VAXCYTE | $8.7B | +93.70% | +20.57% | +10.65% | 3.9 | Up | Up |
| NUVL | NUVALENT-A | $8.4B | +50.06% | -1.75% | +13.04% | 3.5 | Up | Up |
| IBRX | IMMUNITYBIO | $8.4B | +201.12% | +17.05% | -4.37% | 9.7 | Neutral | Up |
| CYTK | Cytokinetics | $8.2B | +74.03% | +4.38% | +6.65% | 3.4 | Neutral | Up |
| HALO | Halozyme Therape | $8.1B | +17.52% | -4.60% | +7.85% | 2.7 | Neutral | Neutral |
| KRYS | KRYSTAL BIOTECH | $8B | +61.53% | -4.66% | +8.34% | 3.3 | Up | Up |
| KYMR | KYMERA THERAP | $7.2B | +205.80% | +24.50% | +13.04% | 4.2 | Up | Up |
| ERAS | ERASCA | $7B | +1523.91% | +122.99% | +53.49% | 6.5 | Up | Up |
| APGE | APOGEE THERAP | $6.8B | +155.94% | +10.93% | +37.58% | 5.2 | Up | Up |
| PTGX | Protagonist Ther | $6.8B | +130.95% | +26.22% | +7.10% | 4.0 | Up | Up |
| ACLX | ARCELLX | $6.7B | +82.16% | +66.95% | +0.18% | 0.1 | Up | Up |
| SYRE | Spyre Therap | $6.1B | +410.53% | +109.68% | +72.78% | 6.1 | Up | Up |
| CELC | CELCUITY | $6.1B | +1033.72% | +17.65% | +18.89% | 4.8 | Up | Up |
| CGON | CG ONCOLOGY | $6.1B | +250.78% | +25.75% | +10.39% | 4.3 | Up | Up |
| COGT | COGENT BIOSCIS | $6B | +746.31% | -7.94% | +10.04% | 4.6 | Neutral | Up |
| PTCT | PTC Therapeutics | $5.9B | +46.57% | -6.52% | +8.16% | 3.4 | Up | Up |
| RYTM | RHYTHM PHARM | $5.8B | +43.37% | -19.85% | -2.89% | 5.1 | Down | Down |
| 0 | 0 | 0 | 0 | Bullish | Bullish |